$ cat ./records/gates-foundation-pledges-1-6-billion-to-gavi-6-0-2026-2030-at-bru-2025.txt
Gates Foundation Pledges $1.6 Billion to Gavi 6.0 (2026–2030) at Brussels Immunisation Summit
[RECORD.TXT] · cat --full
At the Global Summit on Health and Prosperity through Immunisation in Brussels on June 25, 2025, the Gates Foundation committed $1.6 billion to Gavi's 2026–2030 cycle — helping secure more than $9 billion of an $11.9 billion target amid sharp cuts to US global health funding. Gavi 6.0 aims to immunise at least 500 million children, save over 8 million lives, and expand malaria and HPV vaccine coverage. The Gates Foundation has contributed over $7.7 billion to Gavi since 2000, making it Gavi's largest private funder.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Pledges $100 Million to Global Financing Facility for Women's and Children's Health 2026–2030
Next →
Breakthrough Energy Ventures Invests in Savor — Butter Made Directly from Carbon
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.